Researchers have identified a gene
variant that suppresses the desire to drink alcohol, an advance that could lead
to development of drugs to regulate liquor consumption. The findings are based
on the largest genome wide association meta analysis and replication study to
date, mapping and comparing the genetic of over 105,000 light and heavy social
drinkers, researchers said. The study identified a variation in the beta-Klotho
gene linked to the regulation of social alcohol consumption. The less frequent
variant – seen in approximately 40% of the people in this study – is associated
with a decreased desire to drink alcohol. Excessive alcohol consumption is a
major public health problem worldwide, causing more than 3 million deaths per
year. Researchers worked on beta-Klotho and the liver hormone fibroblast growth
factor 21 (FGF21) that binds to the beta-Klotho-FGF21 receptor complex. They conducted
experiments in mice to better understand the role of beta-Klotho in alcohol
drinking behavior. The beta-Klotho gene directs the production of the beta-Klotho
protein that forms part of a receptor complex in the brain. The study could
lead to development of drugs to regulate alcohol consumption – possibly even in
those with drinking problems, researchers said. A shift from heavy to moderate social
drinking could have major public health benefits, such as reduced
cardiovascular disease risk. The study compared the genetics of light and heavy
social drinkers of European ancestry participating in nearly four dozen other
large population studies worldwide. In addition to providing samples for
genetic analysis, the participants answered questionnaires on their weekly
drinking habits. Heavy drinking was defined as more than 21 drinks per week for
women. Light drinking was considered to be 14 drinks or less per week for men
and seven drinks or less per week for women.
No comments:
Post a Comment